Finepoint Capital LP Galapagos Nv Transaction History
Finepoint Capital LP
- $963 Million
- Q3 2024
A detailed history of Finepoint Capital LP transactions in Galapagos Nv stock. As of the latest transaction made, Finepoint Capital LP holds 557,762 shares of GLPG stock, worth $14.9 Million. This represents 1.67% of its overall portfolio holdings.
Number of Shares
557,762
Previous 542,762
2.76%
Holding current value
$14.9 Million
Previous $13.4 Million
19.39%
% of portfolio
1.67%
Previous 3.87%
Shares
9 transactions
Others Institutions Holding GLPG
# of Institutions
84Shares Held
12.3MCall Options Held
69.1KPut Options Held
42.7K-
Bvf Inc San Francisco, CA1.57MShares$42.1 Million1.44% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.41MShares$37.8 Million0.76% of portfolio
-
Prosight Management, LP Dallas, TX1.03MShares$27.6 Million7.95% of portfolio
-
Logos Global Management LP San Francisco, CA800KShares$21.4 Million3.05% of portfolio
-
Primecap Management CO Pasadena, CA720KShares$19.3 Million0.02% of portfolio
About GALAPAGOS NV
- Ticker GLPG
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,835,500
- Market Cap $1.76B
- Description
- Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...